zepbound/mounjaro/tirzepatide FDA approves Zepbound for weight loss Zepbound vs Mounjaro: Whats the

Gluten-free and soy-free

This triagonist profile differentiates retatrutide from existing anti-obesity therapies such as semaglutide, a GLP-1 receptor agonist, and tirzepatide, a dual GLP-1/GIP agonist, both of which lack glucagon receptor activity (Hamrick et al., 2024)

This may reduce follicle sensitivity to DHT without systemic hormonal effects, avoiding the sexual side effects associated with finasteride while still protecting hair follicles from androgen damage

Community starting-dose pattern: A subset of community protocols use 20 mcg for the first 2-3 days to assess hypoglycemia response before stepping up to 50 mcg

It offers only compounded semaglutide and compounded tirzepatide injections

Many patients report that appetite suppression becomes noticeably stronger by week three, even at these lower doses